Towards pancreatic cancer diagnosis using EIS biochips
نویسندگان
چکیده
منابع مشابه
Pancreatic cancer: diagnosis and management.
Although only 32,000 new cases of adenocarcinoma of the pancreas occur in the United States each year, it is the fourth leading cause of cancer deaths in this country. The overall five-year survival rate is 4 percent, and localized, resectable disease has only a 17 percent survival rate. Risk factors include smoking, certain familial cancer syndromes, and familial chronic pancreatitis. The link...
متن کاملTowards Prediction of Pancreatic Cancer Using SVM Study Model
Pancreatic cancer is known to be a difficult disease to diagnose early, and early research mainly focused on predicting the survival rate of pancreatic cancer patients. The correct prediction of the various disease states can greatly benefit the patient and also assist the design of effective and personalized therapeutics. The issue of how to integrate the available laboratory data with classif...
متن کاملPancreatic Cancer: Pathogenesis and Diagnosis.
Pancreatic cancer is a fatal malignancies which is predominantly seen in men and at advanced age (40-85 years) and has an aggressive course. Its frequency is gradually increasing over the past years. It accounts for 2% of all cancers and 5% of cancer-related deaths. Pancreatic cancer takes the first place among asymptomatic cancers. Ninety percent of cases are adenocarcinomas. Ten percent of th...
متن کاملPremalignant Pancreatic Cancer Diagnosis Using Proteomic Pattern Analysis
Pancreatic cancer is one of the deadliest cancers due to the fact that it does not exhibit symptoms in the early stages. Furthermore, when pancreatic cancer gets diagnosed, it is usually too late. Consequently, early diagnosis is highly essential. The dawn of proteomics has brought with it a glimpse of hope of uncovering biomarkers that can be indicative of early pancreatic cancer. Proteome pro...
متن کاملDevelopment towards Compact Nitrocellulose-Based Interferometric Biochips for Dry Eye MMP9 Label-Free In-Situ Diagnosis
A novel compact optical biochip based on a thin layer-sensing surface of nitrocellulose is used for in-situ label-free detection of metalloproteinase (MMP9) related to dry eye disease. In this article, a new integrated chip with different interferometric transducers layout with an optimal sensing surface is reported for the first time. We demonstrate that specific antibodies can be immobilized ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Lab on a Chip
سال: 2013
ISSN: 1473-0197,1473-0189
DOI: 10.1039/c2lc41127j